Ibrahim, D., Yahya, N. (2023). Therapeutic Potential of Epigallocatechin-3-Gallate as a DYRK1A Inhibitor in Diabetes Mellitus: An Overview. Alustath, 20(2), 168-173. doi: 10.33899/iphr.2023.141712.1048
Doaa Khalid Ibrahim; Nooralhuda Akram Yahya. "Therapeutic Potential of Epigallocatechin-3-Gallate as a DYRK1A Inhibitor in Diabetes Mellitus: An Overview". Alustath, 20, 2, 2023, 168-173. doi: 10.33899/iphr.2023.141712.1048
Ibrahim, D., Yahya, N. (2023). 'Therapeutic Potential of Epigallocatechin-3-Gallate as a DYRK1A Inhibitor in Diabetes Mellitus: An Overview', Alustath, 20(2), pp. 168-173. doi: 10.33899/iphr.2023.141712.1048
Ibrahim, D., Yahya, N. Therapeutic Potential of Epigallocatechin-3-Gallate as a DYRK1A Inhibitor in Diabetes Mellitus: An Overview. Alustath, 2023; 20(2): 168-173. doi: 10.33899/iphr.2023.141712.1048


Journal Management System. Powered by ejournalplus.com